Has John Hummel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $274,860 in general payments to John Hummel, MD across 375 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Hummel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Hummel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Hummel, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1356346704

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 70.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $59,431 and has fallen 59.3% since, to $24,178 in 2025. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$274,860in general payments, 2019–2025

Across 375 payments — averaging $732.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$195K
Volta Medical Inc$33K
Abbott$25K
Biosense Webster, Inc.$14K
Philips North America LLC$4K
Baylis Medical Company Inc$2K
plus $2K from 8 others

$1,118,002in research payments, 2019–2025

Across 130 payments — averaging $8600.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$546K
Cortex, Inc.$209K
Volta Medical Inc$193K
Boston Scientific$77K
Abbott$70K
Atricure, Inc.$17K
plus $7K from 1 others

What the payments were for

Consulting fees$69,19025%
Speaking & faculty fees$164,01360%
Travel & lodging$30,41511%
Food & beverage$11,1724%
Education$710%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	260	$194,924
Volta Medical Inc	26	$32,615
Abbott	58	$25,056
Biosense Webster, Inc.	14	$13,764
Philips North America LLC	4	$4,444
Baylis Medical Company Inc	1	$2,019
EBR Systems, Inc.	2	$1,127
Altathera Pharmaceuticals LLC	2	$393
Ablacon, Inc.	2	$266
Acutus Medical, Inc.	1	$102
Boston Scientific	2	$71
Catheter Precision Inc.	1	$34
Atricure, Inc.	1	$29
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$118,560
VX1$32,094
TACTICATH$11,871
Carto 3 System$10,380
TACTICATH ABLATION CATHETER, SENSOR ENABLED$5,525
Spectranetics Undiv$3,750
Carto 3$3,175
Carto Smarttouch$3,150
Carto CFAE$3,150
CartoSound$3,150
Arctic Front$2,345
VersaCross Access Solution$2,019
AVEIR$1,637
AMPLATZER Occluders$1,400
TactiCath Quartz CFA Catheter$1,399
CARDIOBLATE CRYOFLEX$1,043
AMPLATZER AMULET$974
EVERA MRI XT DR SURESCAN$795
EPD Solutions Und$600
Ensite Cardiac Mapping System$590

How this compares

$274,860 in reported general payments places this provider in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$212,465

Medicare patients

1,017

Services billed

1,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	362	$407,139
XareltoRivaroxaban	55	$63,502
Dofetilide	151	$37,202
Mexiletine Hcl	61	$10,480
Amiodarone Hcl	192	$5,113
Metoprolol Succinate	174	$2,165
Diltiazem 24hr Er (Cd)Diltiazem Hcl	91	$2,158
Flecainide Acetate	37	$1,891
SotalolSotalol Hcl	127	$1,766
Clonidine	15	$816
Potassium Chloride	33	$690
Atenolol	37	$601
Klor-Con M20Potassium Chloride	22	$565
Carvedilol	50	$376
Nebivolol Hcl	11	$275

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Columbus

Anish AminColumbus$1.1M
Auroa BadinColumbus$188K
Ralph AugostiniColumbus$174K
David NemerColumbus$97K
Eugene FuColumbus$96K
Ankur ShahColumbus$75K
Sampath GundaColumbus$73K
Sreedhar BillakantyColumbus$64K
Salvatore SavonaColumbus$49K
Natee SirinvaravongColumbus$44K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →